The Gap
The United States spends $13,432 per person on healthcare every year. The next highest-spending comparable wealthy nation spends roughly half that. Americans pay more than citizens of Germany, Japan, Australia, France, Canada, or any of the other high-income democracies — and by nearly every major outcome measure, they receive less in return.
Life expectancy in the United States stands at 79.0 years, 3.7 years below the comparable country average of 82.7 years. The US ranks last in overall healthcare performance among ten high-income nations according to the Commonwealth Fund’s 2024 Mirror Mirror report — a ranking that reflects access, administrative efficiency, equity, and health outcomes simultaneously. American infant mortality rates rank 32nd among 38 OECD member countries. Medical debt, which does not exist as a meaningful phenomenon in any other wealthy country, affects an estimated 100 million Americans who collectively owe $220 billion, according to the Consumer Financial Protection Bureau.
These are not contested figures. They are drawn from government data, nonpartisan research institutions, and international health organizations. They describe a system that costs more and delivers less than any comparable alternative currently operating in the world.
The question this series examines is straightforward: why, and what does the evidence show about alternatives?
What This Series Covers
Single-payer healthcare — most commonly discussed in the United States as Medicare for All — is the proposal most frequently advanced as the structural alternative to the current system. It is also among the most frequently mischaracterized. Its costs and its international track record are disputed in ways this series addresses directly.
This ten-part series examines the evidence without advocacy for a predetermined conclusion. Each part addresses one dimension of the debate in full — the terminology and mechanics, the real costs to families and employers, the major objections and what the research shows about them, the international models and their outcomes, the human consequences of the current system’s coverage gaps, the racial dimensions of healthcare inequality, the documented fraud within Medicare’s privatized programs, the political and financial obstacles to reform, and the ideological arguments on all sides.
By the end of the series, a reader who has followed it in full will have encountered the strongest available evidence on each side of every significant question. The goal is not to reach a conclusion on the reader’s behalf. The goal is to ensure the conclusion they reach is as well-informed as the evidence allows.
The Current Moment
The political context in which this series is published is not static. Several developments in 2025 and 2026 have sharpened the stakes of the healthcare debate.
The Congressional Budget Office projects that Medicaid cuts included in current federal legislation will result in 15 million Americans losing health coverage over the next decade and a $1.1 trillion reduction in health sector spending. Family insurance premiums have risen 26% over five years, with employer-sponsored family coverage averaging $26,993 in 2025 according to the KFF Employer Health Benefits Survey. Marketplace premiums rose approximately 26% in 2026 as ACA subsidies expired, with some states seeing increases above 30%. The nonpartisan Medicare Payment Advisory Commission found that private insurers overbilled Medicare by $84 billion in 2025 alone through a practice known as upcoding — adding unsupported diagnosis codes to inflate payments. The Department of Justice has an open criminal case against the largest health insurer in the country.
These developments are documented context for the series, not conclusions about what should be done. What the evidence shows about the available alternatives — and what tradeoffs each involves — is what the parts that follow are for.
A Note on Sources
Every claim in this series is attributed to an identifiable source. Where government data, academic research, and industry figures conflict, the conflict is noted and the sources named. Conservative and nonpartisan sources are cited alongside progressive ones wherever they address the same evidence — not to create a false appearance of balance, but because the strongest version of an evidence-based argument does not depend on who is making it.
The sources for this part are listed below. Each subsequent part carries its own sourcing section in the same format.
Sources
KFF 2025 Employer Health Benefits Survey — annual survey of employer-sponsored insurance costs and coverage, published by KFF (formerly Kaiser Family Foundation).
Commonwealth Fund Mirror Mirror 2024 — comparative analysis of healthcare system performance across ten high-income nations across five domains: access to care, care process, administrative efficiency, equity, and health care outcomes.
Congressional Budget Office — analysis of Medicaid provisions in current federal legislation, 2025.
Medicare Payment Advisory Commission (MedPAC) — March 2025 Report to Congress on Medicare Advantage payment accuracy and overpayments.
Consumer Financial Protection Bureau — medical debt data, 2024.
OECD Health Statistics 2024 — international comparative data on healthcare spending, life expectancy, and infant mortality across member nations.
The Complete Single Payer Healthcare Series
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.